149 results
Page 2 of 8
8-K
t4z44 qsdvnuww
19 Dec 22
Vaxart Names Phillip Lee as Chief Financial Officer
5:25pm
8-K
EX-99.1
4dx5egqnl49v8qi
8 Nov 22
Vaxart Provides Business Update and Reports Third Quarter 2022 Financial Results
4:10pm
S-8
EX-5.1
fwr5cagdzfl02sh8e9w
21 Oct 22
Registration of securities for employees
9:04pm
8-K
EX-99.2
ag42qmes6brk pf1j
1 Sep 22
Regulation FD Disclosure
7:05am
8-K
EX-99.1
cw6zsfzk19paqz9ilr0k
25 Aug 22
Vaxart Announces Highly Regarded Biotech Executive Elaine J. Heron, Ph.D. Joins Board of Directors
4:09pm
8-K
s5i5cmej
25 Aug 22
Vaxart Announces Highly Regarded Biotech Executive Elaine J. Heron, Ph.D. Joins Board of Directors
4:09pm
8-K
EX-99.1
gjc5eohx9
28 Jun 22
Other Events
5:09pm
8-K
EX-10.2
y8chq 07xvsqk
11 May 22
Departure of Directors or Certain Officers
5:27pm
8-K
EX-10.1
l9ycbj
21 Sep 21
Entry into a Material Definitive Agreement
4:18pm
8-K
EX-10.2
ex7iurzgngm4s
21 Sep 21
Entry into a Material Definitive Agreement
4:18pm
424B5
4cc4qu7a8h8m87ydztv
15 Sep 21
Prospectus supplement for primary offering
9:47pm
8-K
EX-5.1
bltxfzwo1 zp2zwy
15 Sep 21
Entry into a Material Definitive Agreement
9:47pm
8-K
EX-1.1
uyn41o5rj 9qfo1s4b6i
15 Sep 21
Entry into a Material Definitive Agreement
9:47pm
8-K
EX-99.1
9ktpkmazdaoyv6jzo
23 Aug 21
Vaxart Announces Highly Regarded Biotech Executive Julie M. Cherrington, Ph.D., Joins Board of Directors
4:23pm
8-K
EX-3.1
txxey6o1b x61
14 Apr 21
Amendments to Articles of Incorporation or Bylaws
11:07am